This affects the blood flow necessary for the cochleas healthy function, leading to an imbalance in the inner ears fluids
A high urinary methylmalonic acid result helps confirm B12 deficiency
Long-Term Considerations While clinical trials up to 24 weeks demonstrate excellent safety, data on continuous use beyond 6-12 months remains limited
Even if the product could be reclassified to make it available for sale in pharmacies, it could not be used more frequently than every 2 3 months, so reclassification to a Pharmacy medicine would not help those who require more frequent injections. and then they also state: Our current advice to private clinics administering vitamin B12 injections which are not licensed medicinal products intravenously for non-medicinal purposes is that we do not regard these to be medicines and that they fall outside of the remit of the MHRA
Final Research Tips Here are some final reminders to ensure your research stays on track: Keep detailed records of reconstitution dates, storage conditions, and dosing schedules
High-Strength Formula: Each serving contains 500g of B12
